{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:04:50Z","timestamp":1787321090623,"version":"build-2736575974"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Health Econ Health Policy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s40258-026-01055-1","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:43:57Z","timestamp":1783521837000},"page":"909-924","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Cost Effectiveness of Treatment Strategies for Depression in Ethiopia: A Multiple Cohort Markov Model Analysis"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5473-3857","authenticated-orcid":false,"given":"Yared Belete","family":"Belay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7127-9462","authenticated-orcid":false,"given":"Cathrine","family":"Mihalopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7959-3149","authenticated-orcid":false,"given":"Lidia","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2359-6823","authenticated-orcid":false,"given":"Yong Yi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"1055_CR1","unstructured":"American Psychiatric Association. What is depression? 14 June 2024. https:\/\/www.psychiatry.org\/patients-families\/depression\/what-is-depression."},{"key":"1055_CR2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2024.266","author":"J Rong","year":"1990","unstructured":"Rong J, Wang X, Cheng P, Li D, Zhao D. Global, regional and national burden of depressive disorders and attributable risk factors, from 1990 to 2021: results from the 2021 Global Burden of Disease study. Br J Psychiatry. 1990. https:\/\/doi.org\/10.1192\/bjp.2024.266.","journal-title":"Br J Psychiatry"},{"key":"1055_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jpsychires.2019.08.002","volume":"126","author":"Q Liu","year":"2020","unstructured":"Liu Q, He H, Yang J, et al. Changes in the global burden of depression from 1990 to 2017: findings from the Global Burden of Disease study. J Psychiatr Res. 2020;126:134\u201340.","journal-title":"J Psychiatr Res"},{"key":"1055_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s40273-021-01019-4","volume":"39","author":"PE Greenberg","year":"2021","unstructured":"Greenberg PE, Fournier A-A, Sisitsky T, et al. The economic burden of adults with major depressive disorder in the United States (2010 and 2018). Pharmacoeconomics. 2021;39:653\u201365.","journal-title":"Pharmacoeconomics"},{"key":"1055_CR5","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","volume":"391","author":"A Cipriani","year":"2018","unstructured":"Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391:1357\u201366.","journal-title":"Lancet"},{"key":"1055_CR6","volume-title":"Mental health gap action programme (mhGAP) guideline for mental, neurological and substance use disorders","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. Mental health gap action programme (mhGAP) guideline for mental, neurological and substance use disorders. World Health Organization; 2023."},{"key":"1055_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/amhs.amhs_7_18","volume":"6","author":"OJ Fasipe","year":"2018","unstructured":"Fasipe OJ. Neuropharmacological classification of antidepressant agents based on their mechanisms of action. Arch Med Health Sci. 2018;6:81\u201394.","journal-title":"Arch Med Health Sci"},{"key":"1055_CR8","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1177\/070674371305800702","volume":"58","author":"P Cuijpers","year":"2013","unstructured":"Cuijpers P, Berking M, Andersson G, et al. A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. Can J Psychiatry. 2013;58:376\u201385.","journal-title":"Can J Psychiatry"},{"key":"1055_CR9","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1176\/appi.ajp.2010.10101411","volume":"168","author":"P Cuijpers","year":"2011","unstructured":"Cuijpers P, Geraedts AS, van Oppen P, et al. Interpersonal psychotherapy for depression: a meta-analysis. Am J Psychiatry. 2011;168:581\u201392.","journal-title":"Am J Psychiatry"},{"key":"1055_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.eurpsy.2006.11.001","volume":"22","author":"P Cuijpers","year":"2007","unstructured":"Cuijpers P, van Straten A, Warmerdam L. Problem solving therapies for depression: a meta-analysis. Eur Psychiatry. 2007;22:9\u201315.","journal-title":"Eur Psychiatry"},{"key":"1055_CR11","volume-title":"MhGAP intervention guide for mental, neurological and substance use disorders in non-specialized health settings: mental health gap action programme (mhGAP)","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. MhGAP intervention guide for mental, neurological and substance use disorders in non-specialized health settings: mental health gap action programme (mhGAP). World Health Organization; 2016."},{"key":"1055_CR12","unstructured":"Food medicine and healthcare administration and control authority (FMHACA). Standard treatment guidelines for general hospitals; 2014. 30 June 2026. https:\/\/www.efda.gov.et\/publication\/stg-general-hospital\/"},{"key":"1055_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2018-000895","volume":"3","author":"PB James","year":"2018","unstructured":"James PB, Wardle J, Steel A, et al. Traditional, complementary and alternative medicine use in Sub-Saharan Africa: a systematic review. BMJ Glob Health. 2018;3:e000895.","journal-title":"BMJ Glob Health"},{"key":"1055_CR14","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13643-023-02398-9","volume":"12","author":"N Tuasha","year":"2023","unstructured":"Tuasha N, Fekadu S, Deyno S. Prevalence of herbal and traditional medicine in Ethiopia: a systematic review and meta-analysis of 20-year studies. Syst Rev. 2023;12:232.","journal-title":"Syst Rev"},{"key":"1055_CR15","unstructured":"World Health Organization. Depression. 03 September 2024. https:\/\/www.who.int\/health-topics\/depression."},{"key":"1055_CR16","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.jad.2021.09.038","volume":"295","author":"T Mekonen","year":"2021","unstructured":"Mekonen T, Chan GC, Connor JP, et al. Estimating the global treatment rates for depression: a systematic review and meta-analysis. J Affect Disord. 2021;295:1234\u201342.","journal-title":"J Affect Disord"},{"key":"1055_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40258-016-0280-z","volume":"15","author":"EA Zegeye","year":"2017","unstructured":"Zegeye EA, Mbonigaba J, Kaye SB, et al. Economic evaluation in Ethiopian healthcare sector decision making: perception, practice and barriers. Appl Health Econ Health Policy. 2017;15:33\u201343.","journal-title":"Appl Health Econ Health Policy"},{"key":"1055_CR18","first-page":"329","volume":"30","author":"M Mobinizadeh","year":"2016","unstructured":"Mobinizadeh M, Raeissi P, Nasiripour AA, et al. The health systems\u2019 priority setting criteria for selecting health technologies: a systematic review of the current evidence. Med J Islam Repub Iran. 2016;30:329.","journal-title":"Med J Islam Repub Iran"},{"key":"1055_CR19","unstructured":"Leelahanaj T. The cost-effectiveness of aripiprazole as adjunctive therapy in major depressive disorder: Thai economic model. J Med Assoc Thailand\u00a0=\u00a0Chotmaihet Thangphaet. 2010;93:S43\u201350."},{"key":"1055_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1590\/S1020-49892008001000002","volume":"24","author":"M Machado","year":"2008","unstructured":"Machado M, Lopera MM, Diaz-Rojas J, et al. Pharmacoeconomics of antidepressants in moderate-to-severe depressive disorder in Colombia. Rev Panam Salud Publica. 2008;24:233\u20139.","journal-title":"Rev Panam Salud Publica"},{"key":"1055_CR21","doi-asserted-by":"crossref","unstructured":"Machado Ma, Iskedjian M, Ruiz IeA, et al. The economic impact of introducing serotonin-noradrenaline reuptake inhibitors into the Brazilian national drug formulary: cost-effectiveness and budget-impact analyses. Pharmacoeconomics. 2007;25:979\u201390.","DOI":"10.2165\/00019053-200725110-00007"},{"key":"1055_CR22","first-page":"127","volume":"11","author":"D Siskind","year":"2008","unstructured":"Siskind D, Baingana F, Kim J. Cost-effectiveness of group psychotherapy for depression in Uganda. J Ment Health Policy Econ. 2008;11:127\u201333.","journal-title":"J Ment Health Policy Econ"},{"key":"1055_CR23","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jval.2011.11.009","volume":"15","author":"B Prukkanone","year":"2012","unstructured":"Prukkanone B, Vos T, Bertram M, et al. Cost-effectiveness analysis for antidepressants and cognitive behavioral therapy for major depression in Thailand. Value Health. 2012;15:S3\u20138.","journal-title":"Value Health"},{"key":"1055_CR24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.vhri.2013.06.004","volume":"2","author":"M Saylan","year":"2013","unstructured":"Saylan M, Treur M, Postema R, et al. Cost-effectiveness analysis of aripiprazole augmentation treatment of patients with major depressive disorder compared to olanzapine and quetiapine augmentation in Turkey: a microsimulation approach. Value Health Reg Issues. 2013;2:171\u201380.","journal-title":"Value Health Reg Issues"},{"key":"1055_CR25","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s40273-023-01257-8","volume":"41","author":"YB Belay","year":"2023","unstructured":"Belay YB, Engel L, Lee YY, et al. Cost effectiveness of pharmacological and non-pharmacological treatments for depression in low-and middle-income countries: a systematic literature review. Pharmacoeconomics. 2023;41:651\u201373.","journal-title":"Pharmacoeconomics"},{"key":"1055_CR26","unstructured":"CCEMG\u2013EPPI Centre Cost Converter. CCEMG-EPPI-Centre Cost Converter v.1.4 [Internet]. [cited 2026 May 24]. https:\/\/eppi.ioe.ac.uk\/costconversion\/."},{"key":"1055_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/heapol\/czaa073","volume":"35","author":"M Haacker","year":"2020","unstructured":"Haacker M, Hallett TB, Atun R. On discount rates for economic evaluations in global health. Health Policy Plan. 2020;35:107\u201314.","journal-title":"Health Policy Plan"},{"key":"1055_CR28","unstructured":"International Monetary Fund. Consumer Price Index (CPI). 2024. 03 September 2024. https:\/\/data.imf.org\/en\/datasets\/IMF.STA:CPI."},{"key":"1055_CR29","doi-asserted-by":"publisher","first-page":"238146832110610","DOI":"10.1177\/23814683211061097","volume":"7","author":"D Husereau","year":"2022","unstructured":"Husereau D, Drummond M, Augustovski F, et al. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. MDM Policy Pract. 2022;7:23814683211061096.","journal-title":"MDM Policy Pract"},{"key":"1055_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1592596","author":"BB Bifftu","year":"2018","unstructured":"Bifftu BB, Takele WW, Guracho YD, et al. Depression and its help seeking behaviors: a systematic review and meta\u2010analysis of community survey in Ethiopia. Depress Res Treat. 2018. https:\/\/doi.org\/10.1155\/2018\/1592596.","journal-title":"Depress Res Treat"},{"key":"1055_CR31","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/S0140-6736(09)60046-5","volume":"373","author":"A Cipriani","year":"2009","unstructured":"Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet. 2009;373:746\u201358.","journal-title":"Lancet"},{"key":"1055_CR32","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cct.2015.05.009","volume":"45","author":"SA Doi","year":"2015","unstructured":"Doi SA, Barendregt JJ, Khan S, et al. Advances in the meta-analysis of heterogeneous clinical trials I: the inverse variance heterogeneity model. Contemp Clin Trials. 2015;45:130\u20138.","journal-title":"Contemp Clin Trials"},{"key":"1055_CR33","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1177\/0272989X18793394","volume":"38","author":"YY Lee","year":"2018","unstructured":"Lee YY, Le LK-D, Stockings EA, et al. Estimation of a relative risk effect size when using continuous outcomes data: an application of methods in the prevention of major depression and eating disorders. Med Decis Mak. 2018;38:866\u201380.","journal-title":"Med Decis Mak"},{"key":"1055_CR34","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/wps.20493","volume":"17","author":"P Cuijpers","year":"2018","unstructured":"Cuijpers P, Karyotaki E, Reijnders M, et al. Psychotherapies for depression in low-and middle-income countries: a meta-analysis. World Psychiatry. 2018;17:90\u2013101.","journal-title":"World Psychiatry"},{"key":"1055_CR35","doi-asserted-by":"publisher","unstructured":"Tong L, Miguel C, Panagiotopoulou O-M, et al. Psychotherapy for adult depression in low-and middle-income countries: an updated systematic review and meta-analysis. Psychol Med. 2023;53(16):7473\u20137483. https:\/\/doi.org\/10.1017\/S0033291723002246","DOI":"10.1017\/S0033291723002246"},{"key":"1055_CR36","doi-asserted-by":"crossref","unstructured":"Lee YY, Le LK-D, Lal A, et al. The cost-effectiveness of delivering universal psychological interventions in schools to prevent depression among Australian adolescents: a model-based economic evaluation. Mental Health Prev. 2021;24:200213.","DOI":"10.1016\/j.mhp.2021.200213"},{"key":"1055_CR37","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jad.2023.10.047","volume":"344","author":"A Tr\u00f6ger","year":"2024","unstructured":"Tr\u00f6ger A, Miguel C, Ciharova M, et al. Baseline depression severity as moderator on depression outcomes in psychotherapy and pharmacotherapy. J Affect Disord. 2024;344:86\u201399.","journal-title":"J Affect Disord"},{"key":"1055_CR38","unstructured":"Tan-Torres Edejer T, Baltussen R, Adam T, et al. Making choices in health: WHO guide to cost-effectiveness analysis. 2003. 30 June 2026. https:\/\/iris.who.int\/handle\/10665\/42699"},{"issue":"8","key":"1055_CR39","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1080\/j.1440-1614.2005.01652.x","volume":"39","author":"T Vos","year":"2005","unstructured":"Vos T, Corry J, Haby MM, Carter R, Andrews G. Cost-effectiveness of cognitive\u2013behavioural therapy and drug interventions for major depression. Aust N Z J Psychiatry. 2005;39(8):683\u201392. https:\/\/doi.org\/10.1080\/j.1440-1614.2005.01652.x.","journal-title":"Aust N Z J Psychiatry"},{"key":"1055_CR40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S2215-0366(21)00384-9","volume":"9","author":"C Hanlon","year":"2022","unstructured":"Hanlon C, Medhin G, Dewey ME, et al. Efficacy and cost-effectiveness of task-shared care for people with severe mental disorders in Ethiopia (TaSCS): a single-blind, randomised, controlled, phase 3 non-inferiority trial. Lancet Psychiatry. 2022;9:59\u201371.","journal-title":"Lancet Psychiatry"},{"key":"1055_CR41","unstructured":"Global Burden of Disease Collaborative Network. Global burden of disease study 2021 (GBD 2021) results. Seattle: Institute for Health Metrics and Evaluation (IHME); 2024."},{"key":"1055_CR42","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1176\/appi.ajp.2013.13030325","volume":"171","author":"P Cuijpers","year":"2014","unstructured":"Cuijpers P, Vogelzangs N, Twisk J, et al. Comprehensive meta-analysis of excess mortality in depression in the general community versus patients with specific illnesses. Am J Psychiatry. 2014;171:453\u201362.","journal-title":"Am J Psychiatry"},{"key":"1055_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069637","volume":"8","author":"AJ Ferrari","year":"2013","unstructured":"Ferrari AJ, Charlson FJ, Norman RE, et al. The epidemiological modelling of major depressive disorder: application for the Global Burden of Disease Study 2010. PLoS ONE. 2013;8:e69637.","journal-title":"PLoS ONE"},{"key":"1055_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1478-7954-1-4","volume":"1","author":"JJ Barendregt","year":"2003","unstructured":"Barendregt JJ, Van Oortmarssen GJ, Vos T, et al. A generic model for the assessment of disease epidemiology: the computational basis of DisMod II. Popul Health Metrics. 2003;1:1\u20138.","journal-title":"Popul Health Metrics"},{"key":"1055_CR45","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1007\/s11136-024-03735-8","volume":"33","author":"YB Belay","year":"2024","unstructured":"Belay YB, Mihalopoulos C, Lee YY, et al. Health-related quality of life and utility values among patients with anxiety and\/or depression in a low-income tertiary care setting: a cross-sectional analysis. Qual Life Res. 2024;33:2819\u201331.","journal-title":"Qual Life Res"},{"key":"1055_CR46","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1017\/S2045796016000469","volume":"26","author":"YY Lee","year":"2017","unstructured":"Lee YY, Barendregt J, Stockings E, et al. The population cost-effectiveness of delivering universal and indicated school-based interventions to prevent the onset of major depression among youth in Australia. Epidemiol Psychiatr Sci. 2017;26:545\u201364.","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"11","key":"1055_CR47","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.61.11.1097","volume":"61","author":"T Vos","year":"2004","unstructured":"Vos T, Haby MM, Barendregt JJ, Kruijshaar M, Corry J, Andrews G. The burden of major depression avoidable by longer-term treatment strategies. Arch Gen Psychiatry. 2004;61(11):1097. https:\/\/doi.org\/10.1001\/archpsyc.61.11.1097.","journal-title":"Arch Gen Psychiatry"},{"key":"1055_CR48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.vhri.2019.08.475","volume":"22","author":"AG Welie","year":"2020","unstructured":"Welie AG, Gebretekle GB, Stolk E, et al. Valuing health state: an EQ-5D-5L value set for Ethiopians. Value Health Reg Issues. 2020;22:7\u201314.","journal-title":"Value Health Reg Issues"},{"key":"1055_CR49","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1177\/0272989X18765184","volume":"38","author":"B Roudijk","year":"2018","unstructured":"Roudijk B, Donders ART, Stalmeier PF. Setting dead at zero: applying scale properties to the QALY model. Med Decis Mak. 2018;38:627\u201334.","journal-title":"Med Decis Mak"},{"key":"1055_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12955-021-01723-x","volume":"19","author":"J Brockbank","year":"2021","unstructured":"Brockbank J, Krause T, Moss E, et al. Health state utility values in major depressive disorder treated with pharmacological interventions: a systematic literature review. Health Qual Life Outcomes. 2021;19:1\u201317.","journal-title":"Health Qual Life Outcomes"},{"key":"1055_CR51","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.clinthera.2011.11.024","volume":"34","author":"HD Anderson","year":"2012","unstructured":"Anderson HD, Pace WD, Libby AM, et al. Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study. Clin Ther. 2012;34:113\u201323.","journal-title":"Clin Ther"},{"key":"1055_CR52","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"AJ Ferrari","year":"2024","unstructured":"Ferrari AJ, Santomauro DF, Aali A, et al. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403:2133\u201361.","journal-title":"Lancet"},{"key":"1055_CR53","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/wps.20701","volume":"19","author":"P Cuijpers","year":"2020","unstructured":"Cuijpers P, Noma H, Karyotaki E, et al. A network meta\u2010analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression. World Psychiatry. 2020;19:92\u2013107.","journal-title":"World Psychiatry"},{"key":"1055_CR54","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0165-0327(97)00117-1","volume":"48","author":"DA Revicki","year":"1998","unstructured":"Revicki DA, Wood M. Patient-assigned health state utilities for depression-related outcomes: differences by depression severity and antidepressant medications. J Affect Disord. 1998;48:25\u201336.","journal-title":"J Affect Disord"},{"key":"1055_CR55","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/heapol\/czv093","volume":"31","author":"KB Strand","year":"2016","unstructured":"Strand KB, Chisholm D, Fekadu A, et al. Scaling-up essential neuropsychiatric services in Ethiopia: a cost-effectiveness analysis. Health Policy Plan. 2016;31:504\u201313.","journal-title":"Health Policy Plan"},{"key":"1055_CR56","doi-asserted-by":"publisher","DOI":"10.2147\/RMHP.S409929","author":"F Habte","year":"2023","unstructured":"Habte F, Shifa M, Berhanu H. Availability, price and affordability of psychotropic medicines in Addis Ababa, Ethiopia. Risk Manag Healthc Policy. 2023. https:\/\/doi.org\/10.2147\/RMHP.S409929.","journal-title":"Risk Manag Healthc Policy"},{"key":"1055_CR57","unstructured":"Management Science for Health (MSH). International Medical Products Price Guide. 2015 ed. 2016. 30 June 2026. https:\/\/msh.org\/resources\/international-medical-products-price-guide-2\/"},{"key":"1055_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0283348","volume":"18","author":"M Teshager","year":"2023","unstructured":"Teshager M, Araya M, Fenta TG. Access to essential psychotropic medicines in Addis Ababa: a cross-sectional study. PLoS ONE. 2023;18:e0283348.","journal-title":"PLoS ONE"},{"key":"1055_CR59","doi-asserted-by":"publisher","first-page":"1242314","DOI":"10.3389\/fpubh.2023.1242314","volume":"11","author":"A Alebachew","year":"2023","unstructured":"Alebachew A, Abdella E, Abera S, et al. Costs and resource needs for primary health care in Ethiopia: evidence to inform planning and budgeting for universal health coverage. Front Public Health. 2023;11:1242314.","journal-title":"Front Public Health"},{"key":"1055_CR60","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1017\/S2045796016000202","volume":"26","author":"Y-P Wang","year":"2017","unstructured":"Wang Y-P, Chiavegatto Filho ADP, Campanha AM, et al. Patterns and predictors of health service use among people with mental disorders in S\u00e3o Paulo metropolitan area, Brazil. Epidemiol Psychiatr Sci. 2017;26:89\u2013101.","journal-title":"Epidemiol Psychiatr Sci"},{"key":"1055_CR61","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2471\/BLT.15.164418","volume":"94","author":"MY Bertram","year":"2016","unstructured":"Bertram MY, Lauer JA, De Joncheere K, et al. Cost-effectiveness thresholds: pros and cons. Bull World Health Organ. 2016;94:925.","journal-title":"Bull World Health Organ"},{"key":"1055_CR62","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1192\/bjp.187.2.106","volume":"187","author":"E Fenwick","year":"2005","unstructured":"Fenwick E, Byford S. A guide to cost-effectiveness acceptability curves. Br J Psychiatry. 2005;187:106\u20138.","journal-title":"Br J Psychiatry"},{"key":"1055_CR63","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","volume":"9","author":"GBD Mental Disorders Collaborators","year":"2022","unstructured":"GBD Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9:137\u201350.","journal-title":"Lancet Psychiatry"},{"key":"1055_CR64","first-page":"37","volume":"4","author":"D Chisholm","year":"2005","unstructured":"Chisholm D. Choosing cost-effective interventions in psychiatry: results from the CHOICE programme of the World Health Organization. World Psychiatry. 2005;4:37.","journal-title":"World Psychiatry"},{"key":"1055_CR65","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1192\/bjp.184.5.393","volume":"184","author":"D Chisholm","year":"2004","unstructured":"Chisholm D, Sanderson K, Ayuso-Mateos JL, et al. Reducing the global burden of depression: population-level analysis of intervention cost-effectiveness in 14 world regions. Br J Psychiatry. 2004;184:393\u2013403.","journal-title":"Br J Psychiatry"},{"key":"1055_CR66","unstructured":"Federal Ministry of Health. National Mental Health Strategy 2020\u20132025. 2020. 30 June 2026. http:\/\/repository.iifphc.org\/handle\/123456789\/1423"},{"key":"1055_CR67","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1192\/bjp.bp.107.038463","volume":"191","author":"D Chisholm","year":"2007","unstructured":"Chisholm D, Lund C, Saxena S. Cost of scaling up mental healthcare in low-and middle-income countries. Br J Psychiatry. 2007;191:528\u201335.","journal-title":"Br J Psychiatry"},{"key":"1055_CR68","unstructured":"World Health Organization. Mental Health Atlas 2020: Ethiopia Country Profile. 2020. 30 June 2026. https:\/\/www.who.int\/publications\/m\/item\/mental-health-atlas-eth-2020-country-profile"},{"key":"1055_CR69","doi-asserted-by":"publisher","DOI":"10.1017\/gmh.2021.32","volume":"8","author":"S Fernando","year":"2021","unstructured":"Fernando S, Brown T, Datta K, et al. The Friendship Bench as a brief psychological intervention with peer support in rural Zimbabwean women: a mixed methods pilot evaluation. Glob Ment Health. 2021;8:e31.","journal-title":"Glob Ment Health"},{"key":"1055_CR70","doi-asserted-by":"publisher","unstructured":"Maji Hailemariam MH, Abebaw Fekadu AF, Medhin Selamu MS, et al. Equitable access to integrated primary mental healthcare for people with severe mental disorders in Ethiopia: a formative study. Int J Equity Health. 2016;15:121. https:\/\/doi.org\/10.1186\/s12939-016-0410-0","DOI":"10.1186\/s12939-016-0410-0"},{"key":"1055_CR71","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.11.04022","author":"J Spagnolo","year":"2021","unstructured":"Spagnolo J, Lal S. Implementation and use of the Mental Health Gap Action Programme Intervention Guide (mhGAP-IG): a review of the grey literature. J Glob Health. 2021. https:\/\/doi.org\/10.7189\/jogh.11.04022.","journal-title":"J Glob Health"},{"key":"1055_CR72","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/heapol\/czw096","volume":"32","author":"LA Robinson","year":"2017","unstructured":"Robinson LA, Hammitt JK, Chang AY, et al. Understanding and improving the one and three times GDP per capita cost-effectiveness thresholds. Health Policy Plan. 2017;32:141\u20135.","journal-title":"Health Policy Plan"},{"key":"1055_CR73","first-page":"22046","volume":"78","author":"ME Thase","year":"2017","unstructured":"Thase ME, Weisler RH, Manning JS, et al. Utilizing the DSM-5 anxious distress specifier to develop treatment strategies for patients with major depressive disorder. J Clin Psychiatry. 2017;78:22046.","journal-title":"J Clin Psychiatry"},{"key":"1055_CR74","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1176\/appi.focus.12.3.347","volume":"12","author":"P Cuijpers","year":"2014","unstructured":"Cuijpers P, Sijbrandij M, Koole SL, et al. Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis. Focus. 2014;12:347\u201358.","journal-title":"Focus"}],"container-title":["Applied Health Economics and Health Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-026-01055-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40258-026-01055-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-026-01055-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:04:09Z","timestamp":1787317449000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40258-026-01055-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1055"],"URL":"https:\/\/doi.org\/10.1007\/s40258-026-01055-1","relation":{},"ISSN":["1175-5652","1179-1896"],"issn-type":[{"value":"1175-5652","type":"print"},{"value":"1179-1896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Yared Belete Belay, Cathrine Mihalopoulos, Lidia Engel, and Yong Yi Lee declare that they have no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data supporting the findings of this study are available within the article or its supplementary materials.","order":2,"name":"Ethics","label":"Availability of Data and Materials","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Input parameter values and generated data are included in this article and the associated Supplementary Materials. The code used to perform the economic modelling and probabilistic sensitivity analysis was provided to peer reviewers during manuscript review and will be available from the first author upon reasonable request.","order":3,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors contributed equally to the concept and design of the study. Belay and Lee contributed by constructing the model and data acquisition. Belay, Mihalopoulos and Lee contributed to data analysis and interpretation of the findings. Belay Drafted the manuscript and all authors provided critical revision of the manuscript for important intellectual content.","order":7,"name":"Ethics","label":"Authors\u2019 Contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}